David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WNR
3026
CALL
DELISTED
Western Refining Inc
WNR
| $494K | ﹤0.01% |
10,000
-20,000
| -67% | -$836K |
|
|
CRZO
3027
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $493K | ﹤0.01% |
9,933
-38,614
| -80% | -$1.81M |
|
|
GLPW
3028
DELISTED
GLOBAL POWER EQUIPMENT GROUP INC COMMON NEW
GLPW
| $493K | ﹤0.01% |
37,361
-10,430
| -22% | -$137K |
|
|
CDR
3029
DELISTED
Cedar Realty Trust, Inc
CDR
| $491K | ﹤0.01% |
9,935
-10,646
| -52% | -$536K |
|
3030
Protalix BioTherapeutics
PLX
$193M
| $489K | ﹤0.01% |
27,460
+9,414
| +52% | +$184K |
|
|
EIGR
3031
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $489K | ﹤0.01% |
57
+14
| +33% | +$122K |
|
|
SPLS
3032
PUT
DELISTED
Staples Inc
SPLS
| $489K | ﹤0.01% |
+30,000
| New | +$504K |
|
|
SGI
3033
DELISTED
Silicon Graphics Intl.
SGI
| $488K | ﹤0.01% |
56,167
-81,650
| -59% | -$804K |
|
|
SGI
3034
CALL
Somnigroup International
SGI
$13.4B
| $485K | ﹤0.01% |
33,600
-115,600
| -77% | -$1.6M |
|
|
SPPI
3035
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $485K | ﹤0.01% |
+79,891
| New | +$532K |
|
|
NYRT
3036
DELISTED
New York REIT, Inc.
NYRT
| $485K | ﹤0.01% |
4,632
-18,206
| -80% | -$1.9M |
|
3037
Insteel Industries
IIIN
$591M
| $484K | ﹤0.01% |
22,395
-4,781
| -18% | -$102K |
|
|
PPBI
3038
DELISTED
Pacific Premier Bancorp
PPBI
| $484K | ﹤0.01% |
29,896
+4,324
| +17% | +$68.9K |
|
3039
CALL
Textron
TXT
$14.3B
| $483K | ﹤0.01% |
10,900
| – | – |
|
|
AMRS
3040
DELISTED
Amyris Inc.
AMRS
| $483K | ﹤0.01% |
13,417
+459
| +4% | +$14.7K |
|
|
NWY
3041
DELISTED
New York & Co Inc
NWY
| $483K | ﹤0.01% |
192,921
-7,002
| -4% | -$16.2K |
|
3042
CALL
Oneok
OKE
$59.5B
| $482K | ﹤0.01% |
10,000
-44,400
| -82% | -$2.03M |
|
|
BIG
3043
CALL
DELISTED
Big Lots, Inc.
BIG
| $480K | ﹤0.01% |
10,000
-10,000
| -50% | -$472K |
|
|
BONT
3044
DELISTED
Bon-Ton Stores Inc/The
BONT
| $480K | ﹤0.01% |
68,960
-20,034
| -23% | -$118K |
|
|
PE
3045
CALL
DELISTED
PARSLEY ENERGY INC
PE
| $479K | ﹤0.01% |
30,000
-14,600
| -33% | -$228K |
|
3046
Pan American Silver
PAAS
$22B
| $477K | ﹤0.01% |
54,429
-67,467
| -55% | -$693K |
|
|
RNDY
3047
DELISTED
ROUNDYS INC COM STK
RNDY
| $477K | ﹤0.01% |
97,490
-20,883
| -18% | -$88.7K |
|
3048
Weis Markets
WMK
$1.76B
| $476K | ﹤0.01% |
9,565
+3,193
| +50% | +$154K |
|
|
NVTA
3049
DELISTED
Invitae Corporation
NVTA
| $476K | ﹤0.01% |
+28,413
| New | +$526K |
|
|
ESND
3050
DELISTED
Essendant Inc.
ESND
| $476K | ﹤0.01% |
11,621
-2,812
| -19% | -$114K |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.